Opened - 17th Mar 2022Closed - 22nd Mar 2022Listed - 30th Mar 2022
Should I apply for Evoq Remedies SME IPO?
A total of 1 recommendations were tracked for Evoq Remedies SME IPO. Out of 1 , 0 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 1 for Avoid and 0 hasn't given any rating. In terms of percentage 0% institutes has rated Evoq Remedies SME IPO for subscribe.
₹27.00 per share
Issue Price
IPO Recommendations (0 Reviews)
Review By
Apply
May Apply
Neutral
Avoid
Not Rated
Count
0
0
0
0
0
%
0
0
0
0
0
Last Updated on 13-May-2026 10:31:37
₹0
Live GMP
1.67x
Subscription
₹9.72 Cr
Total Issue Size
-
Est. Listing
Evoq Remedies SME IPO Recommendations. Total:1, Subscribe:0, Avoid:1
